David Grieve
Impact in
-
- Cardiac Fibrosis and Remodeling
- Cardiovascular Function and Risk Factors
- Chemotherapy-induced cardiotoxicity and mitigation
- Physiology top 1%
- Nitric Oxide and Endothelin Effects
Papers in
-
- Cardiac Fibrosis and Remodeling 20
- Renin-Angiotensin System Studies 5
- Physiology 26
- Nitric Oxide and Endothelin Effects 21
- Co-authors
- Ajay M. Shah (28 shared papers)Alison Cave (17 shared papers)Simon Walker (5 shared papers)Jian‐Mei Li (3 shared papers)Alison C. Brewer (5 shared papers)Emma Robinson (11 shared papers)Brian D. Green (11 shared papers)Robin Ray (2 shared papers)
- Journals
- British Journal of Pharmacology (6 papers)Atherosclerosis (3 papers)Hypertension (3 papers)Journal of Molecular and Cellular Cardiology (3 papers)Stem Cells (3 papers)
- Partner nations
- United KingdomUnited StatesIreland
In The Last Decade
David Grieve
89 papers receiving 5.3k citations
David Grieve's Hit Papers
Peers
Comparison fields: 5 of 123
- Cardiology and Cardiovascular Medicine 1.6k
- Physiology 1.4k
- Endocrinology, Diabetes and Metabolism 723
- Immunology 917
- Pathology and Forensic Medicine 601
Countries citing papers authored by David Grieve
This map shows the geographic impact of David Grieve's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Grieve with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Grieve more than expected).
Fields of papers citing papers by David Grieve
This network shows the impact of papers produced by David Grieve. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Grieve. The network helps show where David Grieve may publish in the future.
Co-authors
The 25 scholars most cited alongside David Grieve, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 91 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | NADPH Oxidases in Cardiovascular Health and Disease Hit paper breakdown → | 2006 | 513 |
| 2 | 2002 | 435 | |
| 3 | 2010 | 362 | |
| 4 | 2003 | 346 | |
| 5 | 2011 | 270 | |
| 6 | 2006 | 254 | |
| 7 | 2008 | 211 | |
| 8 | 2010 | 207 | |
| 9 | 2014 | 169 | |
| 10 | 2017 | 155 | |
| 11 | 2017 | 144 | |
| 12 | 2008 | 131 | |
| 13 | 2020 | 129 | |
| 14 | 2006 | 118 | |
| 15 | 2009 | 115 | |
| 16 | 2009 | 109 | |
| 17 | 2001 | 97 | |
| 18 | 2015 | 89 | |
| 19 | 2004 | 88 | |
| 20 | 2005 | 85 |
About David Grieve
David Grieve is a scholar working on Cardiology and Cardiovascular Medicine, Physiology, Molecular Biology, Endocrinology, Diabetes and Metabolism and Surgery, having authored 91 papers that have together received 5.4k indexed citations. Recurring topics across this work include Nitric Oxide and Endothelin Effects (21 papers), Cardiac Fibrosis and Remodeling (20 papers), Diabetes Treatment and Management (16 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (9 papers), Cardiac Ischemia and Reperfusion (8 papers), Renin-Angiotensin System Studies (5 papers), Regulation of Appetite and Obesity (5 papers) and Pharmacology and Obesity Treatment (5 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (1.6k citations), Physiology (1.4k citations), Endocrinology, Diabetes and Metabolism (723 citations), Immunology (917 citations) and Pathology and Forensic Medicine (601 citations). David Grieve has collaborated with scholars based in United Kingdom, United States and Ireland. Frequent co-authors include Ajay M. Shah, Alison Cave, Simon Walker, Jian‐Mei Li, Alison C. Brewer, Emma Robinson, Brian D. Green, Robin Ray, Mingyou Chen and Nick Gall. Their work appears in journals such as British Journal of Pharmacology, Atherosclerosis, Hypertension, Journal of Molecular and Cellular Cardiology and Stem Cells.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.